Kiniksa Pharmaceuticals Ltd reports results for the quarter ended in September 30 - Earnings Summary

Kiniksa Pharmaceuticals International

29/10/2024 14:21

* Kiniksa Pharmaceuticals Ltd  KNSA.OQ  reported a quarterly
adjusted loss of 18 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of -20 cents.  The mean expectation of
five analysts for the quarter was for earnings of 3 cents per
share. Wall Street expected results to range from -6 cents to 18
cents per share.
    * Revenue rose 67.4% to $112.21 million from a year ago;
analysts
expected $111.52 million. 
    * Kiniksa Pharmaceuticals Ltd's reported EPS for the quarter
was a
loss of 18 cents​.
    * The company reported a quarterly loss of $12.69 million.
    * Kiniksa Pharmaceuticals Ltd shares had risen by 10.4% this
quarter and gained 57.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 52%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Kiniksa
Pharmaceuticals Ltd is 34.00 
This summary was machine generated from LSEG data October 29 at
02:21 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.03           -0.18          Missed
 Jun. 30 2024      -0.07          -0.06          Beat
 Mar. 31 2024      -0.16          -0.25          Missed
 Dec. 31 2023      -0.14          0.35           Beat